StockData
TuHURA Biosciences, Inc./NV logo

TuHURA Biosciences, Inc./NV (HURA) stock

HURANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$1.37−0.03 (-2.14%)

Close on Nov 18, 2026Market cap $87.31MP/E –Yield –

TuHURA Biosciences total assets

Total assets on the balance sheet at the end of each period.

TuHURA Biosciences's total assets was $31.75M at Jun 30, 2026. For fiscal 2025 it was $27.35M, up 587.4% from the year before. Over ten years it grew 65.0% a year on average. The highest annual figure on record is $27.35M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$27.35M+587.4%
FY2023Jun 30, 2023$3.98M-75.1%
FY2022Jun 30, 2022$15.95M+17.8%
FY2021Jun 30, 2021$13.54M+361.0%
FY2020Jun 30, 2020$2.94M-27.2%
FY2019Jun 30, 2019$4.04M-42.9%
FY2018Jun 30, 2018$7.07M-10.6%
FY2017Jun 30, 2017$7.91M+24.5%
FY2016Jun 30, 2016$6.36M+47.2%
FY2013Dec 31, 2013$4.32M+2262.2%
FY2012Dec 31, 2012$182.83K+22611.8%
FY2011Dec 31, 2011$805–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$31.75M-8.3%
Q1 FY2026CQ1 2026Mar 31, 2026$29.70M+102.9%
Q4 FY2025CQ4 2025Dec 31, 2025$27.35M+587.4%
Q3 FY2025CQ3 2025Sep 30, 2025$25.70M+281.3%
Q2 FY2025CQ2 2025Jun 30, 2025$34.62M+249.1%
Q1 FY2025CQ1 2025Mar 31, 2025$14.64M+10.8%
Q4 FY2023CQ2 2023Jun 30, 2023$3.98M-75.1%
Q3 FY2023CQ1 2023Mar 31, 2023$6.74M-47.3%
Q2 FY2023CQ4 2022Dec 31, 2022$9.92M-44.0%
Q1 FY2023CQ3 2022Sep 30, 2022$13.21M-40.9%
Q4 FY2022CQ2 2022Jun 30, 2022$15.95M+17.8%
Q3 FY2022CQ1 2022Mar 31, 2022$12.80M-32.1%
Q2 FY2022CQ4 2021Dec 31, 2021$17.72M-13.5%
Q1 FY2022CQ3 2021Sep 30, 2021$22.34M-3.4%
Q4 FY2021CQ2 2021Jun 30, 2021$13.54M+361.0%
Q3 FY2021CQ1 2021Mar 31, 2021$18.85M+269.5%
Q2 FY2021CQ4 2020Dec 31, 2020$20.49M+214.8%
Q1 FY2021CQ3 2020Sep 30, 2020$23.13M+176.6%
Q4 FY2020CQ2 2020Jun 30, 2020$2.94M-27.2%
Q3 FY2020CQ1 2020Mar 31, 2020$5.10M+107.7%
Q2 FY2020CQ4 2019Dec 31, 2019$6.51M+61.2%
Q1 FY2020CQ3 2019Sep 30, 2019$8.36M+76.1%
Q4 FY2019CQ2 2019Jun 30, 2019$4.04M-42.9%
Q3 FY2019CQ1 2019Mar 31, 2019$2.46M-74.6%
Q2 FY2019CQ4 2018Dec 31, 2018$4.04M-66.9%
Q1 FY2019CQ3 2018Sep 30, 2018$4.75M-67.1%
Q4 FY2018CQ2 2018Jun 30, 2018$7.07M-10.6%
Q3 FY2018CQ1 2018Mar 31, 2018$9.68M+313.4%
Q2 FY2018CQ4 2017Dec 31, 2017$12.22M+239.9%
Q1 FY2018CQ3 2017Sep 30, 2017$14.45M+186.3%
Q4 FY2017CQ2 2017Jun 30, 2017$7.91M+24.5%
Q3 FY2017CQ1 2017Mar 31, 2017$2.34M+102.6%
Q2 FY2017CQ4 2016Dec 31, 2016$3.59M+64.5%
Q1 FY2017CQ3 2016Sep 30, 2016$5.05M+16.9%
Q4 FY2016CQ2 2016Jun 30, 2016$6.36M+17.9%
Q3 FY2016CQ1 2016Mar 31, 2016$1.16M–
Q2 FY2016CQ4 2015Dec 31, 2015$2.18M–
Q4 FY2013CQ4 2013Dec 31, 2013$4.32M–
Q3 FY2013CQ3 2013Sep 30, 2013$5.39M–

More TuHURA Biosciences figures

See a number that looks wrong?